How many patents does
Amgen Research have?
patents
1,132
families
71
granted
221
applications
911
US
117
EP
98
JP
76
WO
59
CN
52
KR
49
RoW
681
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Amgen Research
Top ten assignees appearing on patents
2009 - 2018
2009
| micromet | 39 |
| kischel, roman | 6 |
2018
| amgen research (munich) | 143 |
| amgen | 33 |
| kischel, roman | 6 |
| takeda | 4 |
| boehringer ingelheim international | 2 |
| micromet | 1 |
Amgen Research
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| treatment of acute lymphoblastic leukemia | 87 | 2008 |
| cross-species-specific bispecific binders | 80 | 2007 |
| binding molecules for bcma and cd3 | 61 | 2011 |
| means and methods for treating dlbcl | 54 | 2010 |
| prevention of adverse effects caused by cd3 specific binding domains | 42 | 2010 |
| antibody neutralizers of human granulocyte macrophage colony stimulating factor | 39 | 2005 |
| cross-species-specific psmaxcd3 bispecific single chain antibody | 38 | 2008 |
| dosage regimen for administering a cd19xcd3 bispecific antibody | 36 | 2009 |
| pharmaceutical compositions with resistance to soluble cea | 33 | 2005 |
| antibody constructs for cdh19 and cd3 | 30 | 2013 |